Los encuentros exclusivos son muy importantes ya que proporcionan dos de los objetivos principales de PLGS: la formación y el networking.
El icono indica que el evento se celebrará próximamente.
Puedes seleccionar los eventos que te interesen con los botones de abajo.
Eventos de PLGS
Eventos del sector
Eventos de otras PLG
XIV Asamblea General, Gerona
7th EPLS, Prague
La e-salud al servicio de la cronicidad
Cena estival 2014, Madrid
SWISS HLG: Summer Evening Event
PLG-UK: 30th Anniversary
Desayunos de Trabajo 2014, Barcelona y Madrid
V Curso de Desarrollo de Negocio, Madrid
19th Swiss-HLG Conference
Máster de liderazgo generativo
XIV Asamblea General, Gerona
Gerona, 16-Oct-2014 a 17-Oct-2014
La XIV Asamblea General de PLGS se celebrará en Girona los días 16 y 17 de octubre.
Se celebrará en el Hotel Carlemany, donde compartiremos una comida ligera de bienvenida, tras la cual iniciaremos la Asamblea.
Este año hemos conseguido en exclusiva para nuestros socios el curso titulado “Europe Pharmaceutical Forecasting” impartido por la prestigiosa empresa Kantar, el cual estamos convencidos de que será un éxito.
Esperamos que podaís aprovechar esta oportunidad única de networking, ya que nos reuniremos los responsables de Business Development de las principales compañías del país y tendremos tiempo para poder conversar, analizar oportunidades de negocio, etc.
7th EPLS, Prague
Prague, 23-Sep-2014 a 24-Sep-2014
Sink or Swim in Europe:the Role of Business Development
The 7th edition of the EPLS will take place at the Marriott Prague and as always will include plenty of networking opportunities, with an arrival drinks reception on Monday evening and gala dinner on Tuesday at the stunning Municipal House. With 5 sessions across the two days, including the newly introduced ‘Talking Table’ format featuring 8 topics, the programme covers the key issues for those involved in business development & licensing across the healthcare industry.
To date over 100 executives representing more than 80 companies from 13 countries have already registered.
All registered delegates will have the opportunity to use the online delegate contact system, available from June, in order to arrange meetings during the symposium. There will be an informal (no booking required) one-to-one meeting area available to all delegates throughout the symposium.
SWISS HLG Event
It is a tradition that the Swiss HLG board organizes at the European/International PLG meetings a special networking evening for its members. In Prague we invite all our colleagues to join us for a beer tasting and dinner event at a traditional Czech restaurant in Prague.
SPECIAL DISCOUNT OFFER
As a special discounted rate to companies registering more than delegate, once a colleague has registered at the standard rate, all additional colleagues registering from the same national company will be charged the lower rate of €850. You need to highlight this on your booking form.
If you would like any further information please contact us at admin@plg-uk.com.
EVENT DETAILS
Location: Prague, Czech Republic
Dates: Tuesday 23rd September to Wednesday 24th September 2014
Early Bird Price: €850 (Early Bird Price available until: 30th May 2014)
Discounted Rates for Multiple Bookings: For companies registering more than one delegate, each additional delegate will be able to register at the discounted rate of €850 per delegate, reduced from the standard rate of €975 per delegate.
Normal Price: €975.
EVENT SCHEDULE
Monday 22nd September
18.30 – 20.30
Welcome Drinks Reception Marriott Prague – Bohemia Room Function Area
Tuesday 23rd September
08.00 – 09.00
Registration
09.00 – 09.15
Welcome Address & Introduction Thomas Hoegn, President, EPLC Alexandr Krajhanzl, President, PLG CEE
SESSION A
Keynote Presentations
09.15 – 09.45
A Commercial Overview of the Opportunities in Europe Frederic Desdouits EVP Head of Corporate Business Development, Acquisitions & Marketin Intelligence Pierre Fabre
09.45 – 10.15
Are All the Emerging Markets Paying Their Way? Reiner Christensen, President, Chameleon Pharma Consulting
10.15 – 10.45
New Business Models – Interface with Pharma Manuela Mueller-Gerndt IBM Dach Smarter Healthcare
10.45 – 11.15
Break
SESSION B
European Entry Strategy
11.15 – 12.30
Launch Strategy for Europe with Panel Discussion: Germany – Burkhard Sträter, Sträter Life Sciences GmbH UK – Dominic Hornblow, Head of Legal, UK Marketing Company, AstraZeneca Spain – Rafael Cabrera, Director Business Development & Market Access, UCB Iberia France
12.30 – 13.00
Role of HTA in Assessing BD Opportunities and Deals Monique Martin, VP and General Manager, HEOR Operations Europe, Life Sciences, Optum
13.00 – 14.30
Lunch
SESSION C
Talking Tables on Deal Issues
1. Legal Aspects e.g. Termination Constanze Ulmer-Eilfort Baker & McKenzie
2. IP Aspects, e.g. SPC’s Gerda Redl REDL Life Science Patent Attorneys
4. Performance Issues in Agreements Paul Ranson Pinsent Masons
5. Deal Trends Roger Davies Medius Associates
6. Commerical Issues Thomas Hoegn TH Consulting
7. Due Diligence Issues Irina Staatz-Granzer Staatz Business Development & Strategy
8. Market Forecasting Neil Jamieson, Evaluate & Lisa Urquhart, EP Vantage
14.30 – 15.05
Individual Tables – Round 1
15.05 – 15.20
Break
15.20 – 15.50
Individual Tables – Round 2
15.50 – 17.00
Feedback to Main Group from Table Moderators
18.00 – 22.00
Networking Drinks Reception & Gala Dinner Francouzska Restaurant, Municipal House
Wednesday 24th September
SESSION D
Orphan Drugs
09.00 – 09.30
Regulatory Challenges and Threats in Orphan Drug Development – are Ultra Orphans Easy Ulrich Granzer Granzer Regulatory Consulting
09.30 – 10.00
Building by Acquisition Charlie Alexander Senior Director Business Development Shire Pharmaceuticals
10.00 – 10.30
Derisking Rare Disease Projects Chris Adams CEO Cydan Development
10.30 – 11.00
Break
SESSION E
Local Emerging / Existing Market Issues
11.00 – 11.30
Overview of Local Markets Hynek Valerian Senior Manager, Offering Management, Czech and Slovak Republics IMS Health
11.30 – 12.00
Entering the Market – Challenges and Opportunities Gyorgy Leitner Chief Operating Officer MediFood
12.00 – 12.30
Generics Transition Jerome Silvestre Senior Vice President Sanofi Global Generics Division
12.30 – 13.00
IP Issues in CEE Gerda Redl Patent and Trademark Attorney REDL Life Science Patent Attorneys
13.00 – 14.00
Lunch and Close
La e-salud al servicio de la cronicidad
Madrid, 8-Jul-2014
. Sala de conferencias de Wecare-u
El próximo 8 de julio se celebrará una nueva jornada orientada a analizar las oportunidades que ofrece la e-Health en un sistema sanitario basado en la atención de los pacientes crónicos. El programa consta de dos ponencias y dos mesas de debate.
Una de las ponencias corre a cargo de la Directora General de Salud Pública, Calidad e Innovación del Ministerio de Sanidad, Mercedes Vinuesa. La segunda la pronunciará un director de PwC especializado en tecnologías de salud, Joan Guanyabens.
En cuanto a las mesas, en la primera estarán representadas las comunidades autónomas (Cataluña, Madrid, País Vasco y Galicia) y en la segunda, las compañías farmacéuticas (Merck, Sanofi, Boehringer Ingelheim). En ambas se abordarán experiencias concretas ya puestas en marcha y políticas de futuro.
OBJETIVOS
En esta jornada organizada por El Global y PwC se pretende analizar las oportunidades que ofrece la e-salud al sistema sanitario en su afán de mejorar la atención a los pacientes crónicos, así como las prácticas ya implantadas en nuestro entorno.
Debido al potencial para reducir gastos innecesarios en los sistemas y para la optimización de sus procesos, el mayor impacto de la aplicación de las TIC se espera en términos de ahorro de costes.
Asimismo, se prevén avances relevantes en resultados de salud. Por parte de los profesionales, se espera que los sistemas de e-salud permitan una atención más personalizada y también una mayor satisfacción e implicación de los pacientes en el manejo de su salud.
Mientras, la industria farmacéutica valora las oportunidades que se presentan en los procesos de I+D, en la relación con los pacientes y en las estrategias de adherencia.
VENTAJAS PARA SOCIOS DE PLGS
En línea con las políticas de apoyo a los socios en situación de desempleo y buscando aliviar los costes de todos los cursos y actividades que se proponen, PLGS ha llegado a un acuerdo con los organizadores de esta interesante jornada consiguiendo un descuento interesante para nuestros socios.
El precio para los socios de PLGS será de 60 € (IVA incluido) frente a los 80 € para otros asistentes.
DATOS DE LA JORNADA
El evento se llevará a cabo el martes 8 de julio, de 9:00 a 14:00h.
Como otros años, hemos seleccionado un lugar agradable que nos permita reunirnos, estrechar contactos y disfrutar de la velada, que organizaremos con ilusión: Nos reuniremos el 2 de julio en el Palacio de Cibeles, en Madrid.
Además de la prometedora velada prevista, tenemos el placer de anunciarte que contaremos con la presencia del señor Humberto Arnés a nuestra Cena Estival, donde nos ofrecerá una interesante charla después del cóctel de bienvenida, tras la cuál, podremos hacerle aquellas preguntas que más nos interesen.
El señor Humberto Arnés es Director General de Farmaindustria desde el año 2001 y, en la actualidad, es miembro del Board y Vicepresidente del Executive Committee de la Federación de la Industria Farmacéutica Europea (EFPIA).
Recuerda que este este encuentro es exclusivo para los socios y el coste corre a cargo de la Asociación.
SWISS HLG: Summer Evening Event
Basel, 11-Jun-2014
. Horburg Learning Center
“Trends in Intellectual Property … threat or opportunity for your next licensing deal?”
The foundation of any licensing deal is the intellectual property licensed. Any of the upcoming changes in the statutory, regulatory or economic environment relating to such intellectual property will foreshadow trends in future licensing deals. The Swiss HLG summer evening event 2014 focuses on such trends in intellectual property and their potential impact on licensing deals.
With this summer evening event Swiss HLG has again assembled distinguished speakers willing to share their expertise with us. After each of the short and concise presentations, there will be room for questions and the audience is also invited to participate in the Q&A panel discussion at the end.
AGENDA
1. Trends in IP strategy for young companies – viewed from a larger company David Deperthes – Corporate Head of Business Development at Debiopharm
2. The Unified Patent Court : quo vadis ? Matthias Stolmár – Stolmár and partners
3. Patent system of BRICS countries – challenges and opportunities from a Pharma perspective Markus Gruber and Denis Barbier – Novartis Principal Patent Attorneys
4. Q&A – Panel discussion with all speakers
The presentations and panel discussion will be followed by an Apéro sponsored by Swiss HLG – with room for further discussion and networking …
To register for this summer evening event, please use the following link : register here
Registration Fee :
Members Swiss HLG : free of charge
Non-members : 50 CHF
Registration closes on June 5th, 2014
Thank you in advance for your participation, and – with you – we look forward to a memorable networking event!
SUMMER EVENING EVENT practicalities:
Date : June 11th, 2014 Time : start 18h00 (doors open 17h30) – estimated end 21h00 Place : Novartis , Horburg Learning Center, Müllheimerstr., Basel Click for map Tram No. 1, 8 or 17 “Dreirosenbrücke”, limited parking
La organización PLG UK quiere recordar a los socios la celebración de su encuentro en el 30 Aniversario de la Asociación, donde se entregará el premio «BD Executive of the Year» organizado por Astrazeneca, y el premio «Best BD Newcomer» organizado por PLG UK.
Puedes presentar tus candidaturas antes del 14 de febrero. Igualmente, si deseas asistir al evento, en el programa se incluye el formulario de inscripción.
Although we don’t look old enough, the PLG will be celebrating its 30th anniversary in 2014 with the highlight being the 30th Anniversary Meeting that will consist of the Awards Night Dinner at the Tower of London on Thursday 27th March with a short walk along the River Thames for the AGM and Meeting on Friday 28th March at the Tower Hotel.
The awards dinner will be a black-tie event and guests will be asked to arrive at the Tower of London for 6.30pm for a private tour of the Crown Jewels before taking drinks in the iconic White Tower. To mark the occasion, we have invited Dr Phil Hammond to speak after dinner following his success at our 20th & 25th anniversary events.
Accommodation will be available at discounted rates at the Tower Hotel on Thursday night with the AGM and meeting taking place there on Friday morning. The programme is provisionally titled ‘Business Development – We Live and Learn’ and will finish with lunch on Friday afternoon.
For those who still intend to submit a nomination for either the BD Executive of the Year Award or the Best BD Newcomer Award, the deadline is fast approaching. Please submit any further nominations to Adam Collins by February 14th.
Desayunos de Trabajo 2014, Barcelona y Madrid
Madrid, 25-Mar-2014
. Hotel Petit Palace Savoy. C/ Alfonso XII Nº18.
Barcelona, 26-Mar-2014
. Hotel ABBA Garden. C/ Santa Rosa, Nº33. Esplugues de LLobregat.
Actualización: Disponible presentación del ponente (formato pdf)
Desde la Junta de PLGS seguimos trabajando en las actividades formativas y de networking que caracterizan a nuestra asociación. En esta dirección, nos complace anunciarte que contaremos con la presencia de Andrew Merron, de Decision Resources.
El título de la ponencia será «The Payer Landscape for High-cost Agents in the EU5 – Primary Research Focussed on the Immune and Oncology Markets».
Decision Resources, la compañía de expertos sobre análisis y estrategias biofarmacéuticas, ofrece una rica variedad de publicaciones de investigación , consultoría y servicios de asesoramiento. Durante más de tres décadas han proporcionado información de alto valor y puntos de vista sobre importantes sectores de la industria de la salud.
Con más de 200 empleados a nivel mundial y acceso a casi 10.000 líderes de opinión y especialistas, sus analistas altamente acreditados son capaces de conciliar la práctica del mundo real con las cifras de las fuentes de datos más respetadas de la industria.
V Curso de Desarrollo de Negocio, Madrid
Madrid, 14-Feb-2014 a 15-Feb-2014
Madrid, 21-Feb-2014 a 22-Feb-2014
Dado el éxito de sus anteriores ediciones, nos es grato anunciarte la celebración de laV Edición del Curso de Desarrollo de Negocio, que organiza CESIF en colaboración con PLGS.
Este curso está dirigido a:
Profesionales de la Industria Farmacéutica y Biotecnológica que comienzan o quieren introducirse en el área de Desarrollo de Negocio, con la necesidad de adquirir conocimientos y habilidades prácticas para su inmediata aplicación profesional.
Directores de Unidades de Negocio o Responsables de Área que deben asumir funciones de búsqueda de oportunidades y de negociación de acuerdos locales o regionales.
Directores Generales de filiales que incorporan a sus responsabilidades locales las funciones de Desarrollo de Negocio.
Directores Generales de compañías biotecnológicas que asumen de forma directa las tareas de Desarrollo de Negocio, y buscan un rápido aprendizaje de términos y técnicas usados en el área.
Se impartirá formación teórica en los aspectos más comunes de la actividad (modelos de negocio actualizados, valoración de proyectos, contratos, patentes y marcas, búsqueda de oportunidades, etc.) aportando también una clara orientación práctica, incluyendo casos y simulaciones aplicados a modelos de negocio (comarketing, copromoción y compraventa) y elaboración de key terms basados en ejemplos reales.
El curso se celebrará los días:
14 y 15 de febrero de 2014 (viernes por la tarde y sábado por la mañana)
21 y 22 de febrero de 2014 (viernes por la tarde y sábado por la mañana)
Nuria Marcos Herrezuelo: Directora General. PONS Patentes y Marcas.
Enrique Cruz-Jentoft: Tesorero de la Junta Directiva. PLGS.
El curso esta subvencionado por PLGS de forma que el coste total para socios y/o antiguos Alumnos de CESIF será de 1.800 € frente a los 2100 € de matrícula estándar.
Los participantes recibirán un Diploma acreditativo de asistencia y aprovechamiento expedido por CESIF y PLGS y una suscripción gratuita durante 1 año a la Revista PHARMA MARKET.
Finalmente, aquellos asistentes al curso que quieran ingresar en PLGS gozarán de un 10% de descuento en la cuota de inscripción.
Aquellos interesados pueden solicitar información en CESIF a:
Mª Carmen Sánchez-Girón Email: mcs@cesif.es Teléfono: 91 5938308
19th Swiss-HLG Conference
Switzerland, 2-Feb-2014 a 4-Feb-2014
. Hotel Waldhaus Flims
Forging New Alliances Across Healthcare Sectors 19th Swiss-HLG Conference February 2nd – 4th 2014 Hotel Waldhaus Flims, Switzerland
Our conference directors and Board have been working hard to bring you this much anticipated annual conference- with you, our members and friends, we aim to keep this annual conference as one of the best in the BD world. Our theme explores the fact that the pharma industry isn’t just about pharmaceuticals anymore.Today, pharma business developers count among their colleagues people from other sectors of the healthcare industry, including medical technologies such as diagnostics and devices, and medical nutrition.
Our deal sheets probably reflect this shift to “holistic” healthcare as well; deals combining tracking technology with oral drugs, supportive medical food with pharmaceuticals to enhance nutritional or medical benefits and companion diagnostics to improve the efficacy of treatments in the individual.
Please save this date. Our conference directors are:
The Swiss HLG recognized the important change in the way we business developers do business, and in 2013 we changed our name from the Swiss Pharma Licensing Group to the Swiss Healthcare Licensing Group. Long-term members know that we always have been open to all sectors of the healthcare and life sciences industries, but we changed our name to raise awareness of our diverse and inclusive membership and to enhance our platform for cross-sector networking, deal making and exchanges of know-how and best practices.
Special rate for Flims 2014: To celebrate our first Winter conference as the Swiss HLG, and to encourage as many business developers from the diverse sectors of our industry to attend, we are offering a one-time special rate of CHF 900 for Members and CHF 1380 for non-Members. As we anticipate significant interest, we are limiting the number of attendees to 100 to ensure that we may provide the same quality of conference at the Waldhaus as in past years. Information about how to become a member of the Swiss HLG, and the benefits, is available on our website at www.swisshlg.com.
Be a sponsor!
The Swiss HLG is a non-profit professional association and we rely on the support of healthcare and life science organizations to be able to fulfil our educational and business networking roles. Our conferences are not only an excellent platform for networking with colleagues, but also a good place to showcase and attract partners to your organization.
We have pre-defined sponsoring packages from which you could choose, and we also would be happy to discuss tailor-made packages to suit your goals. Please contact Carina Spaans: carina.spaans@actelion.com
Goodbye to former Board Member, Jonathan Freeman
Jonathan had been on our Board for several years and contributed much to the Swiss HLG. With regrets, he has moved to Boston and has left our Board. We look forward to Jonathan joining us at our upcoming meetings.
Kim Bill, President Swiss Healthcare Licensing Group web: www.swisshlg.com
Actualización: Abierto el plazo de registro
Dear Members & Colleagues,
The Board of the Swiss HLG is pleased to announce the opening of the registration for our 19th conference, Forging New Alliances Across Healthcare Sectors 2 – 4 February 2014 Hotel Waldhaus, Flims, Switzerland
The pharma industry isn’t just about pharmaceuticals anymore. Today, pharma business developers count among their colleagues people from other sectors of the healthcare industry, including medical technologies such as diagnostics and devices, and medical nutrition. Our 2014 annual Winter conference will explore different, and in some cases less well known sectors of our industry and the opportunities for making deals – or forging alliances – among them.
The Swiss HLG recognized this important change in the way we developers do business, and in 2013 we changed our name from the Swiss Pharma Licensing Group to the Swiss Healthcare Licensing Group.
We have planned a special program addressing the trend toward holistic healthcare and cross-sector dealmaking. Among the highlights, executives from Sanofi, Vifor-Fresenius and Novo Nordisk will tell us how their companies have a broad new approach towards fighting diabetes different to traditional pharmaceutical development; we will hear from Qualcomm and Medgate how technologies are improving patients’ access to care and information; and executives from Apidel and NanoIsrael will address new interests in pharmaceutical technologies and what it takes to succeed as a start-up in this new landscape.
For more information on the conference program, please click here.
To register and reserve accommodation, please click here.
For information on becoming a member of the Swiss HLG, and the benefits, please visit our website www.swisshlg.com.
There also will be plenty of opportunities for informal meetings and networking. As always, fireside chats and discussions are traditional hallmarks of the Swiss HLG Winter event.
A must-attend meeting for any BD&L professional! Come join us!
We have a full program of education and networking with sessions led by senior executives from a broad variety of healthcare sectors, including pharma, technologies, telemedicine and data monitoring. Among the highlights, the CEO of Helsinn, Ricardo Braglia, will deliver the keynote address on Helsinn’s new approach to oncology and Novartis’s head of development strategy will talk about innovative trial design using technologies and non-traditional forums. We also focus on the increasingly important disease area of diabetes and different companies’ holistic approaches to patient therapy and control. Our speakers represent the full range of healthcare industry organizations, including academia, biotech and fully integrated global companies.
Special rate for Flims 2014: To celebrate our first Winter conference as the Swiss HLG, and to encourage as many business developers from the diverse sectors of our industry to attend, we are offering a one-time special rate of CHF 900 for Members and CHF 1380 for non-Members. As we anticipate significant interest, we are limiting the number of attendees to 100 to ensure that we may provide the same quality of conference at the Waldhaus as in past years.
For more information on the conference program, please click here.
To register and reserve accommodation, please click here.
For information on becoming a member of the Swiss HLG, and the benefits, please visit our website www.swisshlg.com.
There also will be plenty of opportunities for informal meetings and networking. As always, fireside chats and discussions are traditional hallmarks of the Swiss HLG Winter event.
A must-attend meeting for any BD&L professional! Come join us!
Fruto de las negociaciones de PLGS por proporcionar medidas de valor al socio, es un placer anunciarte el acuerdo llevado a cabo entre ECV y PLGS.
Evolution Creating Value (ECV) es una organización internacional de teóricos y profesionales enfocados en la creación y desarrollo del liderazgo generativo, apoyando el valor emergente de personas, equipos y organizaciones.
Desde ECV nos ofrecen un importante descuento especial del 30% en su MÁSTER DE LIDERAZGO GENERATIVO: Programa dirigido a líderes de Alta Dirección. Recuerda que la oferta es válida hasta el 10 de enero 2014.
La formación será impartida en inglés, con traductor simultáneo.
Se impartirá en el Círculo Ecuestre de Barcelona y se incluyen almuerzos, coffee breaks y material de lectura, de reflexión y de trabajo.
Utilizamos cookies propias y de terceros para analizar nuestros servicios y mejorar la web a partir de tus hábitos de navegación. Puedes configurar tus preferencias en la pestaña que aparece en la parte inferior de la página.
Funcional
Siempre activo
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Estadísticas
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
indica que el evento se celebrará próximamente.
